|
1
|
Russell JA: Management of sepsis. N Engl J
Med. 355:1699–1713. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bone RC: The pathogenesis of sepsis. Ann
Intern Med. 115:457–469. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
IDSA Sepsis Task Force, . Infectious
diseases society of America (IDSA) position statement: Why IDSA did
not endorse the surviving sepsis campaign guidelines. Clin Infect
Dis. 66:1631–1635. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu H, Liu J, Li W, Liu G and Li Z:
LncRNA-HOTAIR promotes TNF-α production in cardiomyocytes of
LPS-induced sepsis mice by activating NF-κB pathway. Biochem
Biophys Res Commun. 471:240–246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cawcutt KA and Peters SG: Severe sepsis
and septic shock: Clinical overview and update on management. Mayo
Clinic Proceedings. Elsevier; pp. 1572–1578. 2014, View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rudiger A and Singer M: Mechanisms of
sepsis-induced cardiac dysfunction. Crit Care Med. 35:1599–1608.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo W, Liu W, Chen G, Hong S, Qian C, Xie
N, Yang X, Sun Y and Xu Q: Water-soluble andrographolide sulfonate
exerts anti-sepsis action in mice through down-regulating p38 MAPK,
STAT3 and NF-κB pathways. Int Immunopharmacol. 14:613–619. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang F, Xue X, Bi J, Zheng L, Zhi K, Gu Y
and Fang G: Long noncoding RNA CCAT1, which could be activated by
c-Myc, promotes the progression of gastric carcinoma. J Cancer Res
Clin Oncol. 139:437–445. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pearson MJ and Jones SW: Review: Long
noncoding RNAs in the regulation of inflammatory pathways in
rheumatoid arthritis and osteoarthritis. Arthritis Rheumatol.
68:2575–2583. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen H, Lan Z, Li Q and Li Y: Abnormal
expression of long noncoding RNA FGD5-AS1 affects the development
of periodontitis through regulating miR-142-3p/SOCS6/NF-κB pathway.
Artif Cells Nanomed Biotechnol. 47:2098–2106. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xi X, Chu Y, Liu N, Wang Q, Yin Z, Lu Y
and Chen Y: Joint bioinformatics analysis of underlying potential
functions of hsa-let-7b-5p and core genes in human glioma. J Transl
Med. 17:1292019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen JQ, Papp G, Szodoray P and Zeher M:
The role of microRNAs in the pathogenesis of autoimmune diseases.
Autoimmun Rev. 15:1171–1180. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zeng L, Cui J, Wu H and Lu Q: The emerging
role of circulating microRNAs as biomarkers in autoimmune diseases.
Autoimmunity. 47:419–429. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feng Y, Niu LL, Wei W, Zhang WY, Li XY,
Cao JH and Zhao SH: A feedback circuit between miR-133 and the
ERK1/2 pathway involving an exquisite mechanism for regulating
myoblast proliferation and differentiation. Cell Death Dis.
4:e9342013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Navickas R, Gal D, Laucevičius A,
Taparauskaitė A, Zdanytė M and Holvoet P: Identifying circulating
microRNAs as biomarkers of cardiovascular disease: A systematic
review. Cardiovasc Res. 111:322–337. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dong Y, Zhao J, Wu CW, Zhang L, Liu X,
Kang W, Leung WW, Zhang N, Chan FK, Sung JJ, et al: Tumor
suppressor functions of miR-133a in colorectal cancer. Mol Cancer
Res. 11:1051–1060. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cui W, Zhang S, Shan C, Zhou L and Zhou Z:
MicroRNA-133a regulates the cell cycle and proliferation of breast
cancer cells by targeting epidermal growth factor receptor through
the EGFR/Akt signaling pathway. FEBS J. 280:3962–3974. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yamasaki T, Yoshino H, Enokida H, Hidaka
H, Chiyomaru T, Nohata N, Kinoshita T, Fuse M, Seki N and Nakagawa
M: Novel molecular targets regulated by tumor suppressors
microRNA-1 and microRNA-133a in bladder cancer. Int J Oncol.
40:1821–1830. 2012.PubMed/NCBI
|
|
19
|
Tsunoda SP, Wiesner B, Lorenz D, Rosenthal
W and Pohl P: Aquaporin-1, nothing but a water channel. J Biol
Chem. 279:11364–11367. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shanahan CM, Connolly DL, Tyson KL, Cary
NR, Osbourn JK, Agre P and Weissberg PL: Aquaporin-1 is expressed
by vascular smooth muscle cells and mediates rapid water transport
across vascular cell membranes. J Vasc Res. 36:353–362. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Verkman AS: More than just water channels:
Unexpected cellular roles of aquaporins. J Cell Sci. 118:3225–3232.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu K, Tsujimoto H, Cha SJ, Agre P and
Rasgon JL: Aquaporin water channel AgAQP1 in the malaria vector
mosquito anopheles gambiae during blood feeding and humidity
adaptation. Proc Natl Acad Sci USA. 108:6062–6066. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yamazato Y, Shiozaki A, Ichikawa D, Kosuga
T, Shoda K, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, et
al: Aquaporin 1 suppresses apoptosis and affects prognosis in
esophageal squamous cell carcinoma. Oncotarget. 9:29957–29974.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tomita Y, Dorward H, Yool AJ, Smith E,
Townsend AR, Price TJ and Hardingham JE: Role of aquaporin 1
signalling in cancer development and progression. Int J Mol Sci.
18:2992017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qin F, Zhang H, Shao Y, Liu X, Yang L,
Huang Y, Fu L, Gu F and Ma Y: Expression of aquaporin1, a water
channel protein, in cytoplasm is negatively correlated with
prognosis of breast cancer patients. Oncotarget. 7:8143–8154. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ogino H, Fujii M, Ono M, Maezawa K, Kizu J
and Hori S: In vivo and in vitro effects of fluoroquinolones on
lipopolysaccharide-induced pro-inflammatory cytokine production. J
Infect Chemother. 15:168–173. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Skelly DT, Hennessy E, Dansereau MA and
Cunningham C: A systematic analysis of the peripheral and CNS
effects of systemic LPS, IL-1β, [corrected] TNF-α and IL-6
challenges in C57BL/6 mice. PLoS One. 8:e691232013.Erratum in: PLoS
One 8: 10.1371/annotation/90c76048-2edd-4315-8404-4d9d8cbd411e,
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Eggesbø JB, Hjermann I, Høstmark AT and
Kierulf P: LPS induced release of IL-1 beta, IL-6, IL-8 and
TNF-alpha in EDTA or heparin anticoagulated whole blood from
persons with high or low levels of serum HDL. Cytokine. 8:152–160.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hotchkiss RS, Moldawer LL, Opal SM,
Reinhart K, Turnbull IR and Vincent JL: Sepsis and septic shock.
Nat Rev Dis Primers. 2:160452016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Iba T, Watanabe E, Umemura Y, Wada T,
Hayashida K, Kushimoto S; Japanese Surviving Sepsis Campaign
Guideline Working Group for disseminated intravascular coagulation,
; Wada H: Sepsis-associated disseminated intravascular coagulation
and its differential diagnoses. J Intensive Care. 7:322019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Prescott HC and Angus DC: Enhancing
recovery from sepsis: A review. JAMA. 319:62–75. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Reinhart K, Daniels R, Kissoon N, Machado
FR, Schachter RD and Finfer S: Recognizing sepsis as a global
health priority-a WHO resolution. N Engl J Med. 377:414–417. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Giza DE, Fuentes-Mattei E, Bullock MD,
Tudor S, Goblirsch MJ, Fabbri M, Lupu F, Yeung SJ, Vasilescu C and
Calin GA: Cellular and viral microRNAs in sepsis: Mechanisms of
action and clinical applications. Cell Death Differ. 23:1906–1918.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hombach S and Kretz M: Non-coding RNAs:
Classification, biology and functioning. Non-coding RNAs in
colorectal cancer. Springer; pp. 3–17. 2016, View Article : Google Scholar
|
|
36
|
Zhang CC and Niu F: LncRNA NEAT1 promotes
inflammatory response in sepsis-induced liver injury via the
Let-7a/TLR4 axis. Int Immunopharmacol. 75:1057312019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen Y, Fu Y, Song YF and Li N: Increased
expression of lncRNA UCA1 and HULC is required for pro-inflammatory
response during LPS induced sepsis in endothelial cells. Front
Physiol. 10:6082019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fang Y, Hu JF, Wang ZH, Zhang SG, Zhang
RF, Sun LM, Cui HW and Yang F: GAS5 promotes podocyte injury in
sepsis by inhibiting PTEN expression. Eur Rev Med Pharmacol Sci.
22:8423–8430. 2018.PubMed/NCBI
|
|
39
|
Lan C, Shi X, Guo N, Pei H and Zhang H:
Value of serum miR-155-5p and miR-133a-3p expression for the
diagnosis and prognosis evaluation of sepsis. Zhonghua Wei Zhong
Bing Ji Jiu Yi Xue. 28:694–698. 2016.(In Chinese). PubMed/NCBI
|
|
40
|
Ahn J and Kim J: Mechanisms and
consequences of inflammatory signaling in the myocardium. Curr
Hypertens Rep. 14:510–516. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fang L, Moore XL, Dart AM and Wang LM:
Systemic inflammatory response following acute myocardial
infarction. J Geriatr Cardiol. 12:305–312. 2015.PubMed/NCBI
|
|
42
|
Hochstadt A, Meroz Y and Landesberg G:
Myocardial dysfunction in severe sepsis and septic shock: More
questions than answers? J Cardiothorac Vasc Anesth. 25:526–535.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Pathan N, Franklin JL, Eleftherohorinou H,
Wright VJ, Hemingway CA, Waddell SJ, Griffiths M, Dennis JL, Relman
DA, Harding SE and Levin M: Myocardial depressant effects of
interleukin 6 in meningococcal sepsis are regulated by p38
mitogen-activated protein kinase. Crit Care Med. 39:1692–1711.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Marchini G, Ståbi B, Kankes K, Lonne-Rahm
S, Østergaard M and Nielsen S: AQP1 and AQP3, psoriasin, and nitric
oxide synthases 1–3 are inflammatory mediators in erythema toxicum
neonatorum. Pediatr Dermatol. 20:377–384. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Trujillo E, González T, Marin R,
Martin-Vasallo P, Marples D and Mobasheri A: Human articular
chondrocytes, synoviocytes and synovial microvessels express
aquaporin water channels; upregulation of AQP1 in rheumatoid
arthritis. Histol Histopathol. 19:435–444. 2004.PubMed/NCBI
|
|
46
|
Rana S, Shahzad M and Shabbir A: Pistacia
integerrima ameliorates airway inflammation by attenuation of
TNF-α, IL-4, and IL-5 expression levels, and pulmonary edema by
elevation of AQP1 and AQP5 expression levels in mouse model of
ovalbumin-induced allergic asthma. Phytomedicine. 23:838–845. 2016.
View Article : Google Scholar : PubMed/NCBI
|
